| scholarly article | Q13442814 |
| P50 | author | Ali Hemmati-Brivanlou | Q67158924 |
| P2093 | author name string | J Massagué | |
| A Hata | |||
| G Lagna | |||
| P2860 | cites work | Activation of signalling by the activin receptor complex | Q24308084 |
| MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling | Q24310282 | ||
| Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes | Q24310852 | ||
| Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4 | Q24314569 | ||
| MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma | Q24315119 | ||
| The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4 | Q24315313 | ||
| MADR1, a MAD-related protein that functions in BMP2 signaling pathways | Q24317247 | ||
| Receptor-associated Mad homologues synergize as effectors of the TGF-beta response | Q24318330 | ||
| Serine phosphorylation, chromosomal localization, and transforming growth factor-beta signal transduction by human bsp-1 | Q24322007 | ||
| Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium | Q24322926 | ||
| Xenopus chordin: a novel dorsalizing factor activated by organizer-specific homeobox genes | Q24607900 | ||
| A structural basis for mutational inactivation of the tumour suppressor Smad4 | Q27740172 | ||
| Cloning and characterization of a novel member of the human Mad gene family (MADH6) | Q28242476 | ||
| The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling | Q28243202 | ||
| Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling | Q28251743 | ||
| The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase | Q28628494 | ||
| DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 | Q29616726 | ||
| Bone morphogenetic proteins: multifunctional regulators of vertebrate development | Q29618986 | ||
| Expression of achaete-scute homolog 3 in Xenopus embryos converts ectodermal cells to a neural fate | Q29619008 | ||
| A transcriptional partner for MAD proteins in TGF-beta signalling | Q29622823 | ||
| Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. | Q34406617 | ||
| Concentration-dependent patterning of the Xenopus ectoderm by BMP4 and its signal transducer Smad1. | Q34437048 | ||
| A truncated bone morphogenetic protein receptor affects dorsal-ventral patterning in the early Xenopus embryo. | Q35844444 | ||
| TGF-beta signalling through the Smad pathway | Q36914476 | ||
| Mammalian dwarfins are phosphorylated in response to transforming growth factor beta and are implicated in control of cell growth | Q37378595 | ||
| GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex | Q37697197 | ||
| Smad5 induces ventral fates in Xenopus embryo | Q38346792 | ||
| Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors | Q41099665 | ||
| The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function | Q41119639 | ||
| Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. | Q41157114 | ||
| A human Mad protein acting as a BMP-regulated transcriptional activator | Q41192122 | ||
| Embryonic patterning: to BMP or not to BMP, that is the question | Q41434992 | ||
| Studies with a Xenopus BMP receptor suggest that ventral mesoderm-inducing signals override dorsal signals in vivo | Q41436510 | ||
| Vertebrate neural induction: inducers, inhibitors, and a new synthesis | Q41496834 | ||
| Activin-like factor from a Xenopus laevis cell line responsible for mesoderm induction | Q41730591 | ||
| Identification of a potent Xenopus mesoderm-inducing factor as a homologue of activin A. | Q41730594 | ||
| Regulation of neural induction by the Chd and Bmp-4 antagonistic patterning signals in Xenopus | Q43411996 | ||
| Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos | Q44061010 | ||
| Injected Xwnt-8 RNA acts early in Xenopus embryos to promote formation of a vegetal dorsalizing center | Q45071731 | ||
| Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4 | Q45345228 | ||
| A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway | Q46482720 | ||
| Activins are expressed early in Xenopus embryogenesis and can induce axial mesoderm and anterior structures | Q46821460 | ||
| Cephalic expression and molecular characterization of Xenopus En-2 | Q46880356 | ||
| Daughters against dpp modulates dpp organizing activity in Drosophila wing development | Q47070119 | ||
| Mothers against dpp encodes a conserved cytoplasmic protein required in DPP/TGF-beta responsive cells | Q47072372 | ||
| Mesodermal induction in early amphibian embryos by activin A (erythroid differentiation factor). | Q47679683 | ||
| Smad6 inhibits signalling by the TGF-beta superfamily | Q48044158 | ||
| Xenopus mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP-2/4 receptor. | Q48061850 | ||
| Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily | Q48064097 | ||
| Follistatin, an antagonist of activin, is expressed in the Spemann organizer and displays direct neuralizing activity | Q48083210 | ||
| Frequency of Smad gene mutations in human cancers. | Q48676822 | ||
| Induction of epidermis and inhibition of neural fate by Bmp-4 | Q52508863 | ||
| A truncated activin receptor inhibits mesoderm induction and formation of axial structures in Xenopus embryos | Q59061571 | ||
| A Dominant Negative Bone Morphogenetic Protein 4 Receptor Causes Neuralization in Xenopus Ectoderm | Q71880118 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | I-SMAD binding | Q14902704 |
| P304 | page(s) | 186-97 | |
| P577 | publication date | 1998-01-15 | |
| P1433 | published in | Genes & Development | Q1524533 |
| P1476 | title | Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor | |
| P478 | volume | 12 |
| Q24298500 | 3-Phosphoinositide-dependent PDK1 negatively regulates transforming growth factor-beta-induced signaling in a kinase-dependent manner through physical interaction with Smad proteins |
| Q28141283 | A Smad transcriptional corepressor |
| Q62016886 | A novel SMAD6 variant in a patient with severely calcified bicuspid aortic valve and thoracic aortic aneurysm |
| Q40768248 | A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor-beta signaling |
| Q28143788 | A role for smad6 in development and homeostasis of the cardiovascular system |
| Q47938281 | A role for the homeobox gene Xvex-1 as part of the BMP-4 ventral signaling pathway |
| Q74671626 | A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3 |
| Q28144663 | Activation of Smad1-mediated transcription by p300/CBP |
| Q39548366 | Activation of c-Jun NH(2)-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor |
| Q46377767 | Activin receptor-like kinase 2 and Smad6 regulate epithelial-mesenchymal transformation during cardiac valve formation |
| Q46500539 | Activin/TGFbeta and BMP crosstalk determines digit chondrogenesis |
| Q24307781 | Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium |
| Q50002288 | Alteration of Epigenetic Regulation by Long Noncoding RNAs in Cancer |
| Q24815989 | An Oct-1 binding site mediates activation of the gata2 promoter by BMP signaling |
| Q38303707 | Antisense targeting of TGF-beta1 augments BMP-induced upregulation of osteopontin, type I collagen and Cbfa1 in human Saos-2 cells |
| Q24634424 | Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7 |
| Q24315751 | Axin is a scaffold protein in TGF-beta signaling that promotes degradation of Smad7 by Arkadia |
| Q36050423 | BMP receptor-activated Smads confer diverse functions during the development of the dorsal spinal cord. |
| Q52180327 | BMP regulates vegetal pole induction centres in early xenopus development. |
| Q36659526 | BMP signaling in the cartilage growth plate. |
| Q34243004 | BMP signaling in the human fetal ovary is developmentally regulated and promotes primordial germ cell apoptosis |
| Q42955471 | BMP-2 and TGF-beta1 differentially control expression of type II procollagen and alpha 10 and alpha 11 integrins in mouse chondrocytes |
| Q35082302 | BMP-2 and TGFβ2 shared pathways regulate endocardial cell transformation |
| Q92602914 | BMP-4 enhances epithelial mesenchymal transition and cancer stem cell properties of breast cancer cells via Notch signaling |
| Q40346961 | BMP-4 induces a Smad-dependent apoptotic cell death of mouse embryonic stem cell-derived neural precursors. |
| Q38364243 | BMP/Smad signaling and embryonic cerebellum development: stem cell specification and heterogeneity of anterior rhombic lip. |
| Q28140674 | BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6 |
| Q35900138 | BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis |
| Q39875703 | BMP4-Smad signaling pathway mediates adriamycin-induced premature senescence in lung cancer cells |
| Q46956041 | BMPs, Smads and metalloproteases: extracellular and intracellular modes of negative regulation |
| Q36003520 | BRCA1 regulates follistatin function in ovarian cancer and human ovarian surface epithelial cells |
| Q51999950 | Bmp and Wnt/beta-catenin signals control expression of the transcription factor Olig3 and the specification of spinal cord neurons. |
| Q36227044 | Bmp indicator mice reveal dynamic regulation of transcriptional response |
| Q42027007 | Bmp signaling exerts opposite effects on cardiac differentiation |
| Q26746964 | Bone Morphogenetic Protein 4 Signalling in Neural Stem and Progenitor Cells during Development and after Injury |
| Q41783158 | Bone Morphogenetic Protein Signaling: Implications in Urology |
| Q38872877 | Bone Morphogenetic Proteins in Vascular Homeostasis and Disease |
| Q48464668 | Bone mesenchymal stem cell-conditioned medium induces the upregulation of Smad6, which inhibits the BMP-4/Smad1/5/8 signaling pathway |
| Q92035626 | Bone morphogenetic protein 2 is a depot-specific regulator of human adipogenesis |
| Q35376245 | Bone morphogenetic protein 4 (BMP-4) and epidermal growth factor (EGF) inhibit metalloproteinase-9 (MMP-9) expression in cancer cells |
| Q36324476 | Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes |
| Q40313640 | Bone morphogenetic protein dominantly suppresses epidermal growth factor-induced proliferative expansion of adult forebrain neural precursors |
| Q34030601 | Bone morphogenetic protein signalling activity distinguishes histological subsets of paediatric germ cell tumours |
| Q64257528 | Bone morphogenetic proteins and inner ear development |
| Q34025148 | Bone morphogenetic proteins and their antagonists: current and emerging clinical uses |
| Q73376498 | Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells |
| Q37035457 | Bone morphogenetic proteins: a review for cranial and maxillofacial surgery |
| Q89697264 | Bu-M-P-ing Iron: How BMP Signaling Regulates Muscle Growth and Regeneration |
| Q34656187 | Burst BMP triggered receptor kinase activity drives Smad1 mediated long-term target gene oscillation in C2C12 cells |
| Q36263679 | CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor beta transcriptional responses in endothelial cells |
| Q30431055 | Cadherin 6B induces BMP signaling and de-epithelialization during the epithelial mesenchymal transition of the neural crest |
| Q44142868 | Calcineurin and NFAT4 induce chondrogenesis |
| Q52164935 | Calmodulin differentially modulates Smad1 and Smad2 signaling. |
| Q33665042 | Can't get no SMADisfaction: Smad proteins as positive and negative regulators of TGF-beta family signals |
| Q33792221 | Candidate Gene Resequencing in a Large Bicuspid Aortic Valve-Associated Thoracic Aortic Aneurysm Cohort: SMAD6 as an Important Contributor. |
| Q36083465 | Cell biology of cardiac cushion development. |
| Q48236427 | Cerebellar deficits and hyperactivity in mice lacking Smad4. |
| Q35080458 | Characterization of negative feedback network motifs in the TGF-β signaling pathway |
| Q47919138 | Characterization of zebrafish smad1, smad2 and smad5: the amino-terminus of smad1 and smad5 is required for specific function in the embryo. |
| Q93187420 | CircPOMT1 and circMCM3AP inhibit osteogenic differentiation of human adipose-derived stem cells by targeting miR-6881-3p |
| Q40459372 | Cloning of Smad2, Smad3, Smad4, and Smad7 from the goldfish pituitary and evidence for their involvement in activin regulation of goldfish FSHbeta promoter activity. |
| Q21284175 | Cloning of a novel signaling molecule, AMSH-2, that potentiates transforming growth factor beta signaling |
| Q42147850 | Computational modelling of Smad-mediated negative feedback and crosstalk in the TGF-β superfamily network |
| Q33722414 | Concise Review: The Potential Use of Intestinal Stem Cells to Treat Patients with Intestinal Failure |
| Q38332721 | Conditional BMP inhibition in Xenopus reveals stage-specific roles for BMPs in neural and neural crest induction |
| Q91844857 | Confirmation of the role of pathogenic SMAD6 variants in bicuspid aortic valve-related aortopathy |
| Q35541207 | Connective tissue disorders and cardiovascular complications: the indomitable role of transforming growth factor-beta signaling |
| Q38038834 | Control of osteogenesis by the canonical Wnt and BMP pathways in vivo: cooperation and antagonism between the canonical Wnt and BMP pathways as cells differentiate from osteochondroprogenitors to osteoblasts and osteocytes. |
| Q24337748 | Control of prostate cell growth: BMP antagonizes androgen mitogenic activity with incorporation of MAPK signals in Smad1 |
| Q39791091 | Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads |
| Q34769120 | Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis |
| Q27621046 | Crystal structure of a transcriptionally active Smad4 fragment |
| Q34117783 | Cytokine modulation of extracellular matrix gene expression: relevance to fibrotic skin diseases |
| Q36142411 | DNMT1-associated long non-coding RNAs regulate global gene expression and DNA methylation in colon cancer. |
| Q28581449 | Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart |
| Q35205890 | Determinants of specificity in TGF-beta signal transduction. |
| Q57462387 | Developmental SMAD6 loss leads to blood vessel hemorrhage and disrupted endothelial cell junctions |
| Q74249537 | Differential expression of cSmad1 and cSmad5 in the primitive streak during chick embryo gastrulation |
| Q28142906 | Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells |
| Q52141299 | Dissection of inhibitory Smad proteins: both N- and C-terminal domains are necessary for full activities of Xenopus Smad6 and Smad7. |
| Q24653375 | Doubly truncated FosB isoform (Delta2DeltaFosB) induces osteosclerosis in transgenic mice and modulates expression and phosphorylation of Smads in osteoblasts independent of intrinsic AP-1 activity |
| Q39698194 | Downregulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-beta1-mediated growth suppression in adult T-cell leukemia/lymphoma |
| Q33534117 | Downstream factors in transforming growth factor-beta family signaling |
| Q35969690 | Dynamics of BMP and Hes1/Hairy1 signaling in the dorsal neural tube underlies the transition from neural crest to definitive roof plate |
| Q24649140 | Effect of interleukin-1beta on osteogenic protein 1-induced signaling in adult human articular chondrocytes |
| Q42488929 | Efficient TGF-beta induction of the Smad7 gene requires cooperation between AP-1, Sp1, and Smad proteins on the mouse Smad7 promoter |
| Q36106667 | Elevating CLIC4 in Multiple Cell Types Reveals a TGF- Dependent Induction of a Dominant Negative Smad7 Splice Variant |
| Q38943396 | Endocardial cell epithelial-mesenchymal transformation requires Type III TGFβ receptor interaction with GIPC. |
| Q39026766 | Endometrial Carcinoma: Specific Targeted Pathways. |
| Q44158978 | Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells |
| Q33820694 | Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta |
| Q43710307 | Expression of TGF-beta superfamily growth factors, their receptors, the associated SMADs and antagonists in five isolated size-matched populations of pre-antral follicles from normal human ovaries |
| Q46461150 | Expression of caveolin-1 in the early phase of beta-TCP implanted in dog mandible |
| Q57849601 | Expression of the inhibitory Smad7 in early mouse development and upregulation during embryonic vasculogenesis |
| Q36258971 | Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2. |
| Q48135442 | Follicle-Stimulating Hormone β-Subunit Potentiates Bone Morphogenetic Protein 9-Induced Osteogenic Differentiation in Mouse Embryonic Fibroblasts. |
| Q33857584 | Functions of mammalian Smad genes as revealed by targeted gene disruption in mice |
| Q24682784 | GATA- and Smad1-dependent enhancers in the Smad7 gene differentially interpret bone morphogenetic protein concentrations |
| Q35799605 | Gene expression in the normal adult human kidney assessed by complementary DNA microarray |
| Q93043673 | Genetic Causes of Craniosynostosis: An Update |
| Q47068915 | Genetic screen for small body size mutants in C. elegans reveals many TGFbeta pathway components |
| Q35494003 | Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response |
| Q33714250 | Genomic characterization of Wilms' tumor suppressor 1 targets in nephron progenitor cells during kidney development. |
| Q39332689 | Genomic organization and modulation of gene expression of the TGF-β and FGF pathways in the allotetraploid frog Xenopus laevis |
| Q37323649 | Growth differentiation factor 5 is a key physiological regulator of dendrite growth during development |
| Q34116893 | Growth factors and their receptors in pancreatic cancer |
| Q40685877 | Growth/differentiation factor-5 induces growth arrest and apoptosis in mouse B lineage cells with modulation by Smad. |
| Q43195204 | Gtpbp2 is required for BMP signaling and mesoderm patterning in Xenopus embryos. |
| Q40352274 | HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells |
| Q33607338 | Heart valve development: endothelial cell signaling and differentiation |
| Q48204643 | Hepatic SMARCA4 predicts HCC recurrence and promotes tumour cell proliferation by regulating SMAD6 expression. |
| Q29619993 | How cells read TGF-beta signals |
| Q40847427 | Hoxa-9 represses transforming growth factor-beta-induced osteopontin gene transcription |
| Q43563905 | Human truncated Smad 6 (Smad 6s) inhibits the BMP pathway in Xenopus laevis |
| Q34367081 | Hyaluronan esters drive Smad gene expression and signaling enhancing cardiogenesis in mouse embryonic and human mesenchymal stem cells |
| Q50298210 | I-Smad competes with Co-Smad for R-Smad1/5/8 |
| Q24310450 | Identification of receptors and signaling pathways for orphan bone morphogenetic protein/growth differentiation factor ligands based on genomic analyses |
| Q40435167 | Induction of ectopic olfactory structures and bone morphogenetic protein inhibition by Rossy, a group XII secreted phospholipase A2. |
| Q36368827 | Inhibition of E-selectin gene expression by transforming growth factor beta in endothelial cells involves coactivator integration of Smad and nuclear factor kappaB-mediated signals |
| Q35996119 | Inhibition of hepcidin transcription by growth factors |
| Q35822572 | Inhibition of lethal inflammatory responses through the targeting of membrane-associated Toll-like receptor 4 signaling complexes with a Smad6-derived peptide. |
| Q40968846 | Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. |
| Q35105653 | Inhibitory SMADs: potential regulators of ovarian function |
| Q40274237 | Inhibitory Smad transcription factors protect arterial endothelial cells from apoptosis induced by BMP4. |
| Q41559221 | Inhibitory Smads differentially regulate cell fate specification and axon dynamics in the dorsal spinal cord |
| Q37923302 | Integrating developmental signals: a Hippo in the (path)way |
| Q38612598 | Interplay of signal mediators of decapentaplegic (Dpp): molecular characterization of mothers against dpp, Medea, and daughters against dpp. |
| Q24598902 | Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk |
| Q28208226 | Lefty inhibits receptor-regulated Smad phosphorylation induced by the activated transforming growth factor-beta receptor |
| Q28268871 | Mads and Smads in TGF beta signalling |
| Q50746835 | Mathematical model of a gene regulatory network reconciles effects of genetic perturbations on hematopoietic stem cell emergence. |
| Q27860785 | Mechanisms of TGF-beta signaling from cell membrane to the nucleus |
| Q34730581 | Mechanisms underlying cytokine-mediated cell-fate regulation in the nervous system |
| Q28510844 | Methylation of Smad6 by protein arginine N-methyltransferase 1 |
| Q40711568 | MiR-23b and miR-199a impair epithelial-to-mesenchymal transition during atrioventricular endocardial cushion formation |
| Q91937134 | MicroRNA-186 improves fracture healing through activating the bone morphogenetic protein signalling pathway by inhibiting SMAD6 in a mouse model of femoral fracture: An animal study |
| Q34590603 | MicroRNAs miR-26a, miR-26b, and miR-29b accelerate osteogenic differentiation of unrestricted somatic stem cells from human cord blood |
| Q42819903 | Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer |
| Q58780867 | MyD88 Regulates the Expression of SMAD4 and the Iron Regulatory Hormone Hepcidin |
| Q36515547 | Myostatin regulation of muscle development: molecular basis, natural mutations, physiopathological aspects |
| Q41833592 | Negative autoregulation of BMP dependent transcription by SIN3B splicing reveals a role for RBM39. |
| Q34609912 | Neural induction, the default model and embryonic stem cells |
| Q35163981 | New intracellular components of bone morphogenetic protein/Smad signaling cascades |
| Q39406800 | Nonsynonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation |
| Q37421707 | Notch regulates BMP responsiveness and lateral branching in vessel networks via SMAD6. |
| Q55363685 | Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition. |
| Q42175822 | Nuclear Smad7 Overexpressed in Mesenchymal Cells Acts as a Transcriptional Corepressor by Interacting with HDAC-1 and E2F to Regulate Cell Cycle |
| Q28288378 | OAZ regulates bone morphogenetic protein signaling through Smad6 activation |
| Q22011195 | OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways |
| Q64108169 | Opposing roles and potential antagonistic mechanism between TGF-β and BMP pathways: Implications for cancer progression |
| Q34202453 | Optimal effector functions in human natural killer cells rely upon autocrine bone morphogenetic protein signaling |
| Q23920947 | Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function |
| Q28569056 | Ovarian follicle populations of the rat express TGF-beta signalling pathways |
| Q26864900 | Overactive bone morphogenetic protein signaling in heterotopic ossification and Duchenne muscular dystrophy |
| Q39647327 | Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues |
| Q34173672 | Patterning and lineage specification in the amphibian embryo |
| Q45886841 | Percutaneous gene therapy heals cranial defects |
| Q44002044 | Phosphorylation regulation of the interaction between Smad7 and activin type I receptor |
| Q28282476 | Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-beta receptors |
| Q36078699 | Pin1 protein regulates Smad protein signaling and pulmonary fibrosis |
| Q34066256 | Plasticity of TGF-β signaling |
| Q39026435 | Posttranslational Regulation of Smads |
| Q28275567 | Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers |
| Q24291512 | Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads |
| Q38386260 | Quantitative Proteomics of the SMAD (Suppressor of Mothers against Decapentaplegic) Transcription Factor Family Identifies Importin 5 as a Bone Morphogenic Protein Receptor SMAD-specific Importin |
| Q96954768 | RIPK3: A New Player in Renal Fibrosis |
| Q35652597 | Regulation of Smad activities |
| Q24290743 | Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase |
| Q33659727 | Regulation of Smad signalling by protein associations and signalling crosstalk |
| Q37437251 | Regulation of TGF-beta signaling by Smad7. |
| Q39029996 | Regulation of TGF-β Family Signaling by Inhibitory Smads. |
| Q41979197 | Regulation of early xenopus embryogenesis by Smad ubiquitination regulatory factor 2. |
| Q37460835 | Regulation of neural specification from human embryonic stem cells by BMP and FGF. |
| Q44346082 | Regulation of nodal and BMP signaling by tomoregulin-1 (X7365) through novel mechanisms |
| Q28510682 | Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor |
| Q40357624 | Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells |
| Q55318093 | Role of Bone Morphogenetic Protein 7 (BMP7) in the Modulation of Corneal Stromal and Epithelial Cell Functions. |
| Q26821836 | Role of endoglin in fibrosis and scleroderma |
| Q39635816 | Role of p38 MAPK pathway in BMP4-mediated Smad-dependent premature senescence in lung cancer cells |
| Q28262241 | Roles for the MH2 domain of Smad7 in the specific inhibition of transforming growth factor-beta superfamily signaling |
| Q38614636 | Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. |
| Q40694927 | SANE, a novel LEM domain protein, regulates bone morphogenetic protein signaling through interaction with Smad1. |
| Q55261894 | SMAD proteins directly suppress PAX2 transcription downstream of transforming growth factor-beta 1 (TGF-β1) signalling in renal cell carcinoma. |
| Q36754616 | SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta. |
| Q24319956 | SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cells |
| Q92357029 | SMAD6 is frequently mutated in nonsyndromic radioulnar synostosis |
| Q55400232 | SMAD6 overexpression leads to accelerated myogenic differentiation of LMNA mutated cells. |
| Q96136372 | SMAD6 variants in craniosynostosis: genotype and phenotype evaluation |
| Q41732765 | SMADs: mediators and regulators of TGF-beta signaling |
| Q24554242 | STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling |
| Q94585789 | Saliva exosomes-derived UBE2O mRNA promotes angiogenesis in cutaneous wounds by targeting SMAD6 |
| Q37490794 | Sending mixed signals: bone morphogenetic protein in myelination and demyelination |
| Q33697455 | Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins |
| Q28585087 | Smad expression during kidney development |
| Q40850821 | Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors |
| Q33674328 | Smad signaling in skeletal development and regeneration |
| Q37061970 | Smad-Dependent Recruitment of a Histone Deacetylase/Sin3A Complex Modulates the Bone Morphogenetic Protein-Dependent Transcriptional Repressor Activity of Nkx3.2 |
| Q38484478 | Smad3 regulates Rho signaling via NET1 in the transforming growth factor-beta-induced epithelial-mesenchymal transition of human retinal pigment epithelial cells |
| Q28138994 | Smad6 as a transcriptional corepressor |
| Q43492573 | Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6. |
| Q24305290 | Smad6 is a protein kinase X phosphorylation substrate and is required for HL-60 cell differentiation |
| Q35243103 | Smad6 is essential to limit BMP signaling during cartilage development |
| Q35122982 | Smad6 promotes neuronal differentiation in the intermediate zone of the dorsal neural tube by inhibition of the Wnt/beta-catenin pathway |
| Q34985673 | Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription |
| Q28239372 | Smad6 represses Dlx3 transcriptional activity through inhibition of DNA binding |
| Q39032523 | Smad6 suppresses the growth and self-renewal of hepatic progenitor cells |
| Q36419275 | Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling |
| Q41734769 | Smad7 and Smad6 differentially modulate transforming growth factor beta -induced inhibition of embryonic lung morphogenesis |
| Q33237935 | Smad7 and protein phosphatase 1alpha are critical determinants in the duration of TGF-beta/ALK1 signaling in endothelial cells. |
| Q24302554 | Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation |
| Q24290777 | Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation |
| Q40920197 | Smad7 differentially regulates transforming growth factor beta-mediated signaling pathways |
| Q38312879 | Smad7 is a TGF-beta-inducible attenuator of Smad2/3-mediated inhibition of embryonic lung morphogenesis |
| Q41009902 | Smad7 is an activin-inducible inhibitor of activin-induced growth arrest and apoptosis in mouse B cells |
| Q38409230 | Smad7 promotes and enhances skeletal muscle differentiation |
| Q28280601 | Smads and early developmental signaling by the TGFbeta superfamily |
| Q40809693 | Smads in human trophoblast cells: expression, regulation and role in TGF-beta-induced transcriptional activity |
| Q40806167 | Smads, TAK1, and their common target ATF-2 play a critical role in cardiomyocyte differentiation. |
| Q24291000 | Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation |
| Q41808610 | Smurf1 regulates neural patterning and folding in Xenopus embryos by antagonizing the BMP/Smad1 pathway |
| Q24303055 | Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane |
| Q34688761 | Spatio-temporal distribution of Smads and role of Smads/TGF-β/BMP-4 in the regulation of mouse bladder organogenesis |
| Q33537701 | Specificity in transforming growth factor-beta signaling pathways |
| Q46511813 | Specificity of the inhibitory effects of Dad on TGF-beta family type I receptors, Thickveins, Saxophone, and Baboon in Drosophila. |
| Q91943837 | Specificity, versatility, and control of TGF-β family signaling |
| Q24628923 | Structural basis for the versatile interactions of Smad7 with regulator WW domains in TGF-β Pathways |
| Q24292106 | Structural basis of Smad1 activation by receptor kinase phosphorylation |
| Q34414642 | Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis |
| Q33790714 | Synexpression groups in eukaryotes |
| Q47786161 | TGF-beta signaling and cancer: structural and functional consequences of mutations in Smads. |
| Q28139850 | TGF-beta signaling by Smad proteins |
| Q47817973 | TGF-beta signaling, Smads, and tumor suppressors |
| Q34353131 | TGF-beta signalling pathways in early Xenopus development. |
| Q28569079 | TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling |
| Q38256407 | TGF-β & BMP receptors endoglin and ALK1: overview of their functional role and status as antiangiogenic targets. |
| Q27025590 | TGF-β - an excellent servant but a bad master |
| Q92883776 | TGF-β family ligands exhibit distinct signalling dynamics that are driven by receptor localisation |
| Q38633657 | TGF-β induces growth suppression in multiple myeloma MM.1S cells via E2F1. |
| Q93036211 | TGF-β/SMAD signaling regulation of mesenchymal stem cells in adipocyte commitment |
| Q37798252 | TGF-β: friend or foe? The role of TGF-β/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy. |
| Q28142605 | TGFbeta signaling in growth control, cancer, and heritable disorders |
| Q34545421 | TGFbeta/BMP inhibits the bone marrow transformation capability of Hoxa9 by repressing its DNA-binding ability |
| Q34121672 | TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells |
| Q35172304 | TGFβ superfamily signaling regulators are differentially expressed in the developing and adult mouse testis |
| Q38325146 | Temporal analysis of the early BMP functions identifies distinct anti-organizer and mesoderm patterning phases |
| Q36682952 | Temporal control of BMP signalling determines neuronal subtype identity in the dorsal neural tube. |
| Q28771732 | Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1 |
| Q39871283 | Tgf-Beta superfamily receptors-targets for antiangiogenic therapy? |
| Q39295657 | The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites |
| Q28276556 | The Discovery and Early Days of TGF-β: A Historical Perspective |
| Q42638343 | The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-beta receptors. |
| Q36294196 | The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling |
| Q35691527 | The Nedd4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture |
| Q92446155 | The Role of Ubiquitination in Regulating Embryonic Stem Cell Maintenance and Cancer Development |
| Q35612296 | The SCL transcriptional network and BMP signaling pathway interact to regulate RUNX1 activity |
| Q38319514 | The Smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor: potential clinical implications |
| Q33857580 | The Smads: transcriptional regulation and mouse models |
| Q34511224 | The TGF-beta--Smad network: introducing bioinformatic tools |
| Q52172698 | The Xvex-1 antimorph reveals the temporal competence for organizer formation and an early role for ventral homeobox genes. |
| Q35037659 | The evolution of signalling pathways in animal development |
| Q37109638 | The homing and inhibiting effects of hNSCs-BMP4 on human glioma stem cells |
| Q36862425 | The murine growth differentiation factor 15 is not essential for systemic iron homeostasis in phlebotomized mice. |
| Q46338473 | The neural plate specifies somite size in the Xenopus laevis gastrula |
| Q33222328 | The role of Smad signaling in hematopoiesis |
| Q54696020 | The role of endogenous bone morphogenetic proteins in normal skeletal repair. |
| Q39171149 | Therapeutic Potential for Bone Morphogenetic Protein 4 in Human Malignant Glioma |
| Q37128066 | To (TGF)beta or not to (TGF)beta: fine-tuning of Smad signaling via post-translational modifications |
| Q36737268 | Tob genes in development and homeostasis |
| Q28208130 | Tob proteins enhance inhibitory Smad-receptor interactions to repress BMP signaling |
| Q29618985 | Transcriptional control by the TGF-beta/Smad signaling system |
| Q34684392 | Transcriptome analysis of newt lens regeneration reveals distinct gradients in gene expression patterns. |
| Q28083526 | Transforming Growth Factor-Beta and Oxidative Stress Interplay: Implications in Tumorigenesis and Cancer Progression |
| Q33930282 | Transforming growth factor beta signaling mediators and modulators |
| Q28286474 | Transforming growth factor beta1 induces nuclear export of inhibitory Smad7 |
| Q24793265 | Transforming growth factor-beta and breast cancer: Transforming growth factor-beta/SMAD signaling defects and cancer |
| Q34438032 | Transforming growth factor-beta signal transduction in epithelial cells. |
| Q37103999 | Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis |
| Q35177514 | Transforming growth factor-beta stimulates epithelial-mesenchymal transformation in the proepicardium |
| Q42100860 | Transgenic analysis of the Smad family of TGF-beta signal transducers in Drosophila melanogaster suggests new roles and new interactions between family members |
| Q33853415 | Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice |
| Q34017313 | Trigenic neural crest-restricted Smad7 over-expression results in congenital craniofacial and cardiovascular defects. |
| Q41259219 | Two locus inheritance of non-syndromic midline craniosynostosis via rare SMAD6 and common BMP2 alleles |
| Q45981141 | Two models of Smad4 and Hoxa9 complex are proposed: structural and interactional perspective. |
| Q24305427 | USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma |
| Q28752508 | Unexpected activities of Smad7 in Xenopus mesodermal and neural induction |
| Q36717858 | Valproic acid suppresses collagen by selective regulation of Smads in conjunctival fibrosis |
| Q35066911 | Vascularization of the developing chick limb bud: role of the TGFbeta signalling pathway |
| Q30421569 | miR-26a is required for skeletal muscle differentiation and regeneration in mice |
| Q35475330 | miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway |
| Q28140333 | Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. THE TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regula |
Search more.